arrow
S

S. Yamamoto

takeda pharmaceutical company limited
H指数:36
被引数:4,150

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SLC52A1 Is a Neofunctionalized Primate Urate Transporter Enabling Intestinal Urate Secretion

SLC52A1 是一个新功能化的灵长类尿酸转运蛋白,能够促进肠道尿酸分泌。

2026-02-260
OAAI
Comparative Biodistribution of AAV1, AAV5, AAV9, and AAVDJ Serotypes in Non-Human Primates following Intra-Cisternal Magna Administration

非人灵长类动物经小脑延髓池内注射后AAV1、AAV5、AAV9和AAVDJ血清型的比较生物分布

2025-09-090
OAAI
Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model
2024-09-260
OAAI
Quantitative Model Analysis and Simulation of Pharmacokinetics and Metastasis-Associated Lung Adenocarcinoma 1 RNA Knockdown Effect After Systemic Administration of Cholesterol-Conjugated DNA/RNA Heteroduplex Oligonucleotide Crossing Blood-Brain Barrier of Mice
2023-01-013
OAAI
Brain microvascular endothelial cells derived from human induced pluripotent stem cells as in vitro model for assessing blood-brain barrier transferrin receptor-mediated transcytosis

人诱导多能干细胞来源的脑微血管内皮细胞作为评估血脑屏障转铁蛋白受体介导的转胞吞作用的体外模型

2022-03-0118
OA
Biodistribution studies for cell therapy products: Current status and issues
2021-12-0121
OAAI
Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS
2021-08-1292
PREAI